Alphatec Holdings Reports 14% Revenue Growth to $192.1 Million in Q1 2026

Alphatec Holdings, Inc. reported a revenue increase of 14% for the first quarter of 2026, generating $192.1 million compared to $169.2 million in the same period of 2025. This growth was attributed to a rise in product volume, driven by an expanding surgeon user base and the adoption of new products. The company's gross profit for the quarter was $136.5 million, up from $116.0 million year-over-year. However, Alphatec recorded a net loss of $33.9 million, a decrease from a net loss of $51.9 million in the prior year, resulting in a net loss per share of $0.22, compared to $0.35 in the same quarter of 2025.

Total operating expenses for the first quarter of 2026 were $159.1 million, slightly down from $160.3 million in the previous year. Research and development expenses rose by 6% to $17.6 million, while sales, general, and administrative expenses increased by 8% to $137.1 million, reflecting higher compensation-related costs. Notably, litigation-related expenses saw a significant decline of 96%, dropping to $0.5 million from $12.2 million, primarily due to a settlement in the previous year. The company also reported a 49% increase in interest expenses, totaling $11.7 million, largely due to the amortization of debt discounts associated with its 2030 Notes.

In terms of operational metrics, Alphatec's cash and cash equivalents decreased to $139.9 million as of March 31, 2026, from $160.8 million at the end of 2025. The company’s total assets increased to $799.5 million, up from $791.2 million, while total liabilities rose to $804.8 million, compared to $778.8 million at the end of the previous year. The increase in liabilities was driven by higher accounts payable and accrued expenses, which rose to $46.0 million and $111.6 million, respectively.

Strategically, Alphatec continues to focus on expanding its product portfolio and market presence. The company markets its products through a network of independent sales agents and direct sales representatives, aiming to penetrate untapped markets and enhance its distribution channels. The company has also made significant investments in research and development to support its growth initiatives. Looking ahead, Alphatec anticipates continued revenue growth driven by increased product adoption and expansion into new markets, although it remains cautious about potential market fluctuations and operational challenges.